Reuters logo
BRIEF-Cadila Healthcare's Zydus gets final nod from U.S. FDA for doxycycline tablets
September 29, 2017 / 6:54 AM / in 25 days

BRIEF-Cadila Healthcare's Zydus gets final nod from U.S. FDA for doxycycline tablets

Sept 29 (Reuters) - Cadila Healthcare Ltd:

* Says Zydus gets final approval from U.S. FDA for doxycycline tablets USP​

* Drug to be manufactured at group's formulations manufacturing facility at Pharma SEZ, Ahmedabad‍​ Source text: bit.ly/2hAO4az Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below